Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas

AUTOR(ES)

Inoue, Kazushi

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

Loss of Dmp1, an Arf transcriptional activator, leads to spontaneous tumorigenesis in mice, causing death from various forms of cancer by two years of age. Retention and expression of the wild-type Dmp1 allele in tumors arising in Dmp1+/− mice demonstrate that Dmp1 can be haplo-insufficient for tumor suppression. The mean latency of Eμ-Myc-induced B-cell lymphomas is halved on a Dmp1−/− or Dmp1+/− genetic background. Although p53 mutations or Arf deletion normally occur in ∼50% of Eμ-Myc-induced lymphomas, Dmp1 loss obviates selection for such mutations, indicating that Dmp1 is a potent genetic modifier of the Arf–p53 pathway in vivo.

Documentos Relacionados

• Disruption of the ARF–Mdm2–p53 tumor suppressor pathway in Myc-induced lymphomagenesis
• Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis
• Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis
• Id2 Is Dispensable for Myc-Induced Epidermal Neoplasia
• Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis